We are live on
!
Find out more
CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
163 hedge funds and large institutions have $1.42B invested in Clovis Oncology, Inc. in 2016 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 49 increasing their positions, 33 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
228% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 18
171% more capital invested
Capital invested by funds: $524M → $1.42B (+$893M)
100% more funds holding in top 10
Funds holding in top 10: 5 → 10 (+5)
48% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 33
47% more call options, than puts
Call options by funds: $71M | Put options by funds: $48.3M
34% more funds holding
Funds holding: 122 → 163 (+41)
Holders
163
Holders Change
+41
Holders Change %
+33.61%
% of All Funds
4.35%
Holding in Top 10
10
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+100%
% of All Funds
0.27%
New
59
Increased
49
Reduced
33
Closed
18
Calls
$71M
Puts
$48.3M
Net Calls
+$22.7M
Net Calls Change
+$24M
Top Buyers
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$28.7M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$13.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$13.4M |
| 4 |
CCM
Consonance Capital Management
New York
|
+$12.8M |
| 5 |
PC
PointState Capital
New York
|
+$12.4M |
Top Sellers
| 1 |
HM
HealthCor Management
New York
|
-$41.8M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$26.1M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$22.5M |
| 4 |
Goldman Sachs
New York
|
-$19.3M |
| 5 |
Morgan Stanley
New York
|
-$14.7M |
